E. Scott Toner
Geen lopende functies
Loopbaan van E. Scott Toner
Eerdere bekende functies van E. Scott Toner
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OPKO HEALTH, INC. | Verkoop & Marketing | 09-04-2014 | 01-01-2015 |
REATA PHARMACEUTICALS, INC. | Verkoop & Marketing | 01-03-2011 | 01-12-2012 |
AMAG PHARMACEUTICALS, INC. | Verkoop & Marketing | 01-03-2007 | 01-10-2010 |
PROTARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2015 | - |
Verkoop & Marketing | 01-01-2015 | - | |
American Association of Kidney Patients, Inc. | Directeur/Bestuurslid | - | - |
Opleiding van E. Scott Toner
Drexel University | Masters Business Admin |
Ithaca College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Sales & Marketing | 4 |
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OPKO HEALTH, INC. | Health Services |
Bedrijven in privébezit | 4 |
---|---|
Proteon Therapeutics, Inc.
Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
American Association of Kidney Patients, Inc. |
- Beurs
- Insiders
- E. Scott Toner
- Ervaring